Pharmaceutical

IBA venture PanTera gains €134m in funding to scale up actinium-225 production

The IBA-SCK CEN joint venture secured funds to increase production of the radioisotope used in cancer therapies.

Sep 12, 2024 - 04:00
IBA venture PanTera gains €134m in funding to scale up actinium-225 production
The IBA-SCK CEN joint venture secured funds to increase production of the radioisotope used in cancer therapies.
Read the original article

Tags:

Previous Article

EASD 2024: Are tetra-agonists the future of metabolic diseases treatment?

Next Article

EASD 2024: Novo Nordisk’s Saxenda shows weight loss in children

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: To make immunotherapy safe for brain tumors, researchers will have to tackle new risks

STAT+: To make immunotherapy safe for brain tumors, res...

Apr 7, 2023

Pharmaceutical Technology Excellence Awards 2024: SecureCHEK AI

Pharmaceutical Technology Excellence Awards 2024: Secur...

Jul 30, 2024

Study suggests Covid rebound is far more common with Paxlovid than without

Study suggests Covid rebound is far more common with Pa...

Nov 13, 2023